<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>10204841</id><passage><infon key="journal">J. Med. Genet.; 1999 Mar; 36(3) 183-6</infon><infon key="year">1999</infon><infon key="article-id_pmc">PMC1734331</infon><infon key="type">title</infon><infon key="authors">Villard L, Bonino MC, Abidi F, Ragusa A, Belougne J, Lossi AM, Seaver L, Bonnefont JP, Romano C, Fichera M, Lacombe D, Hanauer A, Philip N, Schwartz C, Font√©s M</infon><offset>0</offset><text>Evaluation of a mutation screening strategy for sporadic cases of ATR-X syndrome.</text><annotation id="1"><infon key="Identifier">MESH:C538258</infon><infon key="type">Disease</infon><location offset="66" length="14"/><text>ATR-X syndrome</text></annotation></passage><passage><infon key="type">abstract</infon><offset>82</offset><text>We report on the evaluation of a strategy for screening for XNP/ATR-X mutations in males with mental retardation and associated dysmorphology. Because nearly half of the mutations in this gene reported to date fall into a short 300 bp region of the transcript, we decided to focus in this region and to extend the mutation analysis to cases with a negative family history. This study includes 21 mentally retarded male patients selected because they had severe mental retardation and a typical facial appearance. The presence of haemoglobin H or urogenital abnormalities was not considered critical for inclusion in this study. We have identified six mutations which represents a mutation detection rate of 28%. This figure is high enough for us to propose this strategy as a valid first level of screening in a selected subset of males with mental retardation. This approach is simple, does not require RNA preparation, does not involve time consuming mutation detection methods, and can thus be applied to a large number of patients at a low cost in any given laboratory.</text><annotation id="11"><infon key="identifier">546</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">416</infon><location offset="142" length="9"/><text>XNP/ATR-X</text></annotation><annotation id="12"><infon key="Identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="176" length="18"/><text>mental retardation</text></annotation><annotation id="13"><infon key="Identifier">None</infon><infon key="type">Disease</infon><location offset="210" length="13"/><text>dysmorphology</text></annotation><annotation id="14"><infon key="Identifier">MESH:D018567</infon><infon key="type">Disease</infon><location offset="478" length="22"/><text>mentally retarded male</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="501" length="8"/><text>patients</text></annotation><annotation id="16"><infon key="Identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="543" length="18"/><text>mental retardation</text></annotation><annotation id="17"><infon key="Identifier">MESH:D014564</infon><infon key="type">Disease</infon><location offset="628" length="24"/><text>urogenital abnormalities</text></annotation><annotation id="18"><infon key="Identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="924" length="18"/><text>mental retardation</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1108" length="8"/><text>patients</text></annotation></passage></document></collection>